METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE

    公开(公告)号:WO2022036111A1

    公开(公告)日:2022-02-17

    申请号:PCT/US2021/045765

    申请日:2021-08-12

    申请人: IMARA INC.

    IPC分类号: A61P13/08 A61P7/00 C07D487/04

    摘要: The present disclosure relates to methods for decreasing or increasing one or more biomarkers by administering PDE9 pharmaceutical compositions comprising 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one (Compound 1), or a pharmaceutically acceptable salt, solvate, or polymorph thereof, in a patient suffering from sickle cell disease (SCD) and/or sickle cell anemia (SCA).